197 related articles for article (PubMed ID: 33241667)
1. T Cell-Mediated Transport of Polymer Nanoparticles across the Blood-Brain Barrier.
Ayer M; Schuster M; Gruber I; Blatti C; Kaba E; Enzmann G; Burri O; Guiet R; Seitz A; Engelhardt B; Klok HA
Adv Healthc Mater; 2021 Jan; 10(2):e2001375. PubMed ID: 33241667
[TBL] [Abstract][Full Text] [Related]
2. Covalent and Noncovalent Conjugation of Degradable Polymer Nanoparticles to T Lymphocytes.
Thomsen T; Reissmann R; Kaba E; Engelhardt B; Klok HA
Biomacromolecules; 2021 Aug; 22(8):3416-3430. PubMed ID: 34170107
[TBL] [Abstract][Full Text] [Related]
3. Biotin-NeutrAvidin Mediated Immobilization of Polymer Micro- and Nanoparticles on T Lymphocytes.
Ayer M; Burri O; Guiet R; Seitz A; Kaba E; Engelhardt B; Klok HA
Bioconjug Chem; 2021 Mar; 32(3):541-552. PubMed ID: 33621057
[TBL] [Abstract][Full Text] [Related]
4. Strategies for transporting nanoparticles across the blood-brain barrier.
Zhang TT; Li W; Meng G; Wang P; Liao W
Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
[TBL] [Abstract][Full Text] [Related]
5. Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier.
Abadier M; Haghayegh Jahromi N; Cardoso Alves L; Boscacci R; Vestweber D; Barnum S; Deutsch U; Engelhardt B; Lyck R
Eur J Immunol; 2015 Apr; 45(4):1043-58. PubMed ID: 25545837
[TBL] [Abstract][Full Text] [Related]
6. Transport of drugs across the blood-brain barrier by nanoparticles.
Wohlfart S; Gelperina S; Kreuter J
J Control Release; 2012 Jul; 161(2):264-73. PubMed ID: 21872624
[TBL] [Abstract][Full Text] [Related]
7. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
8. Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers.
Mulvihill JJ; Cunnane EM; Ross AM; Duskey JT; Tosi G; Grabrucker AM
Nanomedicine (Lond); 2020 Jan; 15(2):205-214. PubMed ID: 31916480
[TBL] [Abstract][Full Text] [Related]
9. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
Lossinsky AS; Shivers RR
Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
[TBL] [Abstract][Full Text] [Related]
10. Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier.
Cox A; Vinciguerra D; Re F; Magro RD; Mura S; Masserini M; Couvreur P; Nicolas J
Eur J Pharm Biopharm; 2019 Sep; 142():70-82. PubMed ID: 31176723
[TBL] [Abstract][Full Text] [Related]
11. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
12. Targeting central nervous system pathologies with nanomedicines.
Mizrahy S; Gutkin A; Decuzzi P; Peer D
J Drug Target; 2019; 27(5-6):542-554. PubMed ID: 30296187
[TBL] [Abstract][Full Text] [Related]
13. A method for evaluating nanoparticle transport through the blood-brain barrier in vitro.
Guarnieri D; Muscetti O; Netti PA
Methods Mol Biol; 2014; 1141():185-99. PubMed ID: 24567140
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle enabled drug delivery across the blood brain barrier: in vivo and in vitro models, opportunities and challenges.
Gidwani M; Singh AV
Curr Pharm Biotechnol; 2014; 14(14):1201-12. PubMed ID: 24809717
[TBL] [Abstract][Full Text] [Related]
15. Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier.
Andrieux K; Couvreur P
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(5):463-74. PubMed ID: 20049811
[TBL] [Abstract][Full Text] [Related]
16. Folate Receptor α-Modified Nanoparticles for Targeting of the Central Nervous System.
Kuplennik N; Lang K; Steinfeld R; Sosnik A
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39633-39647. PubMed ID: 31532618
[TBL] [Abstract][Full Text] [Related]
17. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-Mediated Drug Delivery: Blood-Brain Barrier as the Main Obstacle to Treating Infectious Diseases in CNS.
Gondim BLC; da Silva Catarino J; de Sousa MAD; de Oliveira Silva M; Lemes MR; de Carvalho-Costa TM; de Lima Nascimento TR; Machado JR; Rodrigues V; Oliveira CJF; Cançado Castellano LR; da Silva MV
Curr Pharm Des; 2019; 25(37):3983-3996. PubMed ID: 31612822
[TBL] [Abstract][Full Text] [Related]
19. Drug delivery to the CNS and polymeric nanoparticulate carriers.
Costantino L
Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
[TBL] [Abstract][Full Text] [Related]
20. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
